Validation strategies for antibodies targeting modified ribonucleotides

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

FIGURE 3.
FIGURE 3.

Antibody specificity against base modifications using dot blot assays. (A) Scheme of the dot blot experimental setup. Unmodified/modified BSA conjugates or oligonucleotides (m5C or C as examples) were spotted on a nylon membrane. After cross-linking and blocking, the membrane was incubated with the primary and secondary antibodies. Methylene blue stains nucleic acids and was used as a loading control. (B) Dot blot experiments, for which modified and unmodified BSA-nucleoside conjugate was used to assess the specificity of the antibodies α-m6A 9B7, α-m5C 32E2, α-Ψ 27C8, and α-m26A 60G3. For m6A, also the m26A-BSA conjugate was spotted to investigate specificity between the two very similar modifications. (C) Dot blot experiments using a modified and a nonmodified 12-mer RNA oligonucleotide as negative control. The antibody staining is shown on the left and the methylene blue staining as a loading control on the right. The dot blots for the antibodies α-m6A 9B7 and Synaptic Systems, α-m5C 32E2, α-Ψ 27C8, and α-m26A 60G3, are depicted.

This Article

  1. RNA 26: 1489-1506